Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>On 31 January, <a href="https://www.smartkarma.com/entities/walmart-inc" target="_blank" data-smartkarma-citation="entities:11134:1" rel="noopener">Walmart (WMT US)</a> announced a 3:1 stock split. For cognoscenti, that meant a Dow Jones Industrial Avg might be in the offing.</li>
<li>The last change to the index was in Aug-2020, spurred by the 4:1 split for <a href="https://www.smartkarma.com/entities/apple-inc" target="_blank" data-smartkarma-citation="entities:666:1" rel="noopener">Apple (AAPL US)</a>. This time, the likely deletion candidate was <a href="https://www.smartkarma.com/entities/walgreens-boots-alliance-inc" target="_blank" data-smartkarma-citation="entities:1118:1" rel="noopener">Walgreens Boots Alliance (WBA US)</a>. </li>
<li>Indeed, last week, the Index Keepers announced <a href="https://www.smartkarma.com/entities/amazon-com-inc" target="_blank" data-smartkarma-citation="entities:409:1" rel="noopener">Amazon.com Inc (AMZN US)</a> would replace Walgreens Boots Alliance on 26 Feb (i.e. WBA would be booted on the close of 23 Feb).</li>
</ul>


On 31 January, Walmart (WMT US) announced a 3:1 stock split. For cognoscenti, that meant a Dow Jones Industrial Avg might be in the offing.
The last change to the index was in Aug-2020, spurred by the 4:1 split for Apple (AAPL US). This time, the likely deletion candidate was Walgreens Boots Alliance (WBA US). 
Indeed, last week, the Index Keepers announced Amazon.com Inc (AMZN US) would replace Walgreens Boots Alliance on 26 Feb (i.e. WBA would be booted on the close of 23 Feb).


Walgreens Boots Alliance (WBA US) - How Do Dow Jones Deletes Do Historically?

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Walgreens Boots Alliance / Equity Bottom-Up

<ul><li>Walgreens Boots Alliance surpassed Wall Street's revenue and earnings expectations, showcasing resilience in a challenging US retail environment.</li><li>This achievement reflects the adept execution and cost discipline in US Retail Pharmacy, sustained robust performance internationally, and progress in US Healthcare profitability initiatives.</li><li>While encountering macroeconomic difficulties and acknowledging structural challenges, Walgreens' management underscores the strategic moves in progress.</li></ul>

Walgreens Boots Alliance surpassed Wall Street's revenue and earnings expectations, showcasing resilience in a challenging US retail environment.This achievement reflects the adept execution and cost discipline in US Retail Pharmacy, sustained robust performance internationally, and progress in US Healthcare profitability initiatives.While encountering macroeconomic difficulties and acknowledging structural challenges, Walgreens' management underscores the strategic moves in progress.

Walgreens Boots Alliance Inc.: The Health & Retail Revolution – Unveiling Their Path To Future Growth! - Major Drivers

<ul><li>Walgreens Boots Alliance, Inc. delivered mixed results for the previous quarter, with revenues above analyst expectations but below-par earnings.</li><li>Walgreens's quarter was marked by solid sales growth and a return to adjusted earnings growth.</li><li>The main part of this plan is the launch of "Walgreens Health," a technology-enabled care model that will give people in local communities more personalized health care.</li></ul>

Walgreens Boots Alliance, Inc. delivered mixed results for the previous quarter, with revenues above analyst expectations but below-par earnings.Walgreens's quarter was marked by solid sales growth and a return to adjusted earnings growth.The main part of this plan is the launch of "Walgreens Health," a technology-enabled care model that will give people in local communities more personalized health care.

Walgreens Boots Alliance Inc.: Decoding Their Strategic Response to Changing Market Trends! - Major Drivers

<ul><li>Walgreens Boots Alliance produced a strong second quarter which happened to be an all-around beat.</li><li>Also, this quarter served as a turning point in their transition to the healthcare industry.</li><li>Besides that, Boots had a fantastic quarter in the international segment, achieving retail comp growth of 16% over the same period last year.</li></ul>

Walgreens Boots Alliance produced a strong second quarter which happened to be an all-around beat.Also, this quarter served as a turning point in their transition to the healthcare industry.Besides that, Boots had a fantastic quarter in the international segment, achieving retail comp growth of 16% over the same period last year.

Walgreens Boots Alliance Inc.: Advancements In Healthcare & Key Drivers

<ul><li>Walgreens’ stock had a disappointing performance during the course of the year but there as been some recovery after a decent result.</li><li>In the quarter pharmacy performance benefitted from the improved trends from maintenance medications and seasonal scripts.</li><li>We provide the stock of Walgreens with a ‘Hold’ rating and a revision in the target price.dditional workstreams for its consumer-facing digital assistant.</li></ul>

Walgreens’ stock had a disappointing performance during the course of the year but there as been some recovery after a decent result.In the quarter pharmacy performance benefitted from the improved trends from maintenance medications and seasonal scripts.We provide the stock of Walgreens with a ‘Hold’ rating and a revision in the target price.dditional workstreams for its consumer-facing digital assistant.

Walgreens Boots Alliance: The CareCentrix Acquisition & Other Drivers

United States

Walgreens Boots Alliance, Inc., operates retail drugstores that offer a wide variety of prescription and non-prescription drugs as well as general goods. Walgreens' also offers health services, including primary and acute care, wellness, pharmacy and disease management services and health and fitness.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Walgreens Boots Alliance (WBA US)